How to Buy Novo Nordisk A S Stock
Novo Nordisk A S
Novo Nordisk A S is a biotech company located in Denmark, which is part of the Healthcare sector, and is traded under the ticker NVO on the NYSE exchange.
Novo Nordisk A S stock last closed at $134.66, up 1.31% from the previous day, and has increased 58.96% in one year. It has overperformed other stocks in the Biotechnology industry by 0.78 percentage points. Novo Nordisk A S stock is currently +78.22% from its 52-week low of $75.56, and -2.62% from its 52-week high of $138.28.
As of May 15, 2024, there are 4.51B NVO shares outstanding. The market value of NVO is $607.32B. In the last 24 hours, 3.71M NVO shares were traded.
How to Buy Novo Nordisk A S Stock
Not sure how to invest in Novo Nordisk A S stock? Here's how.
- Choose where to buy Novo Nordisk A S stock: You need to decide on an online brokerage, but don't worry - we've tried dozens of online brokerages and apps to help you determine where to buy Novo Nordisk A S stock.
- Create your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
- Deposit money your brokerage account: Choose your method of payment and add your info.
- Analyze Novo Nordisk A S stock: The Novo Nordisk A S ticker symbol is NVO. Is Novo Nordisk A S stock a good investment? Should you buy shares of NVO? How do NVO's underlying business fundamentals look? Do top analysts think Novo Nordisk A S is a good buy? Why has NVO's stock price moved recently? (Hint: Our stock analysis website can help you understand if NVO is a good stock to buy).
- Place your NVO trade: Decide if you will purchase NVO shares at the current market price or use a limit order to purchase NVO shares at a specific price.
- Get updates on your NVO position: Create a watchlist to get live updates on your investment in Novo Nordisk A S shares.
Step 1: Choose where to buy Novo Nordisk A S stock
You will need a brokerage account in order to access the NYSE market and buy NVO stock.
Our recommended brokerage: eToro
Based on our analysis, eToro is the best online stock brokerage. Here's why:
- You can invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
- Access to global financial markets: From Tech to Utilities, New York to Shanghai — you can fill your portfolio with stocks from the globe's leading exchanges.
- Social investing: eToro offers a community with more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your stock purchase by opening an account with eToro now.
Open eToro AccountStep 2: Create your brokerage account
Now that you've picked the right brokerage, you need to fill out some personal details so you are able to invest in NVO stock today.
How to Start a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal details to create a new trading account.
- Send your information by pressing the "Create Account" button. Get started with eToro today
Step 3: Deposit money your brokerage account
Now that you've opened your account on mobile trading apps, you can securely and quickly fund your account:
Watch the walkthrough below if you need help transferring funds into your new brokerage account.
Step 4: Analyze Novo Nordisk A S stock
After you have decided on the best place to buy Novo Nordisk A S stock, it's absolutely critical to research their stock prior to investing, so you truly wrap your head around the risk and upside.
Overview of key NVO info
Novo Nordisk A S Zen Score
WallStreetZen was created to help part-time investors perform more in-depth fundamental analysis quickly.
You can view all of the due diligence checks on NVO's stock page.
How is NVO stock valued?
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge NVO's fair value.
Using relative valuations measures:
- NVO may be overvalued based on its P/E ratio of 46.87x, relative to Biotechnology industry P/E ratio of 8.99x
- NVO could be overvalued based on its P/B ratio of 42.67x, relative to Biotechnology industry P/B ratio of 6.09x
- NVO may be overvalued based on its PEG ratio of 16.49x
You can access additional valuation analysis on NVO's stock here.
NVO Financial Health Summary
Pros:
- NVO's operating cash flow of $13.44B allows it to safely service it's debt of $3.87B.
- NVO profit margin has gone up from 32.5% to 36.6% in the past year.
- There are more short-term assets than long-term liabilities on the NVO balance sheet.
- NVO earnings of $16.15B is not sufficient to cover its interest payments.
Cons:
- NVO has a relatively high debt to equity ratio of 2.02.
- There are more short-term liabilities than short-term assets on the NVO balance sheet.
- Total NVO debt is higher than 5 years ago, relative to shareholder equity.
Do Wall Street analysts think it's a good time to buy Novo Nordisk A S stock
Out of 6 Equities analysts who give ratings on NVO, the consensus analyst rating on Novo Nordisk A S is a Strong Buy
Please note that analyst ratings are not recommendations, nor are they investment advice.
Latest NVO Analyst Forecasts
John Eade, a top 5% analyst from Argus Research maintains NVO with a strong buy rating and raises their NVO price target from $110.00 to $115.00, on Dec 1, 2023.
You can dive deeper into what analysts are forecasting on the Novo Nordisk A S stock forecast page.
Metrics for Advanced NVO Traders
NVO Growth Numbers
Last year, NVO earnings were $12.85B. Over the last 5 year, NVO's earnings have gone up by 19.19% per year. This was faster than the Biotechnology industry average of 9.92%.
Last year, NVO revenue was $35.14B. During the past five year, NVO's revenue has increased by 15.46% per year. This was slower than the Biotechnology industry average of 32.04%.
Find out more about NVO's earnings and revenue performance here.
Who is buying/selling NVO?
Over the past year, insiders at NVO have not bought or sold any shares.
Dig into more about who owns NVO stock here.
Can I rely on NVO as an income stream?
Novo Nordisk A S pays a dividend of 1.02%, compared to the Biotechnology industry's average dividend yield of 14.8%. If you owned $1,000 worth of NVO stock, you would have been paid $10.19 last year.
Novo Nordisk A S dividend payments have consistently grown over the past decade but have not remained stable.
Get more data about Novo Nordisk A S dividend yield and history here.
What do other traders have to say about NVO?
One of the biggest reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other community members have to say.
Step 5: Place your NVO trade
You have two primary types of orders:
- Market order: A market order is an order to buy or sell a stock at the best available price.
Market orders are mostly fine. - Limit order: A limit order is an order to buy or sell a stock at a specific price (or better).
If you want to ensure you're buying or selling at a specific price limit, use a limit order.
Hit the Open Trade button and eToro will execute the order.
If you require additional assistance investing in stocks on eToro, watch the helpful video below:
Step 6: Get updates on your NVO position
Now that you own some NVO shares, you'll want to stay up-to-date on your new stock purchase.
Put NVO on a watchlist to get notified of the latest news about your NVO stock.
NVO Feed
How to Buy Stock in Novo Nordisk A S
To summarize, here are the 6 steps to buy stock in Novo Nordisk A S:
- Choose where to buy Novo Nordisk A S stock
- Create your brokerage account
- Deposit money your brokerage account
- Analyze Novo Nordisk A S stock
- Place your NVO trade
- Get updates on your NVO position
If you require a online brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you would like to keep tabs on your investment in Novo Nordisk A S, create your watchlist below.
Other "How To" Guides You May Like
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.